These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 29242073)
1. Abbreviated atovaquone-proguanil prophylaxis regimens in travellers after leaving malaria-endemic areas: A systematic review. Savelkoel J; Binnendijk KH; Spijker R; van Vugt M; Tan K; Hänscheid T; Schlagenhauf P; Grobusch MP Travel Med Infect Dis; 2018; 21():3-20. PubMed ID: 29242073 [TBL] [Abstract][Full Text] [Related]
2. Discontinuing atovaquone/proguanil prophylaxis ad-hoc post-exposure and during-travel dose-sparing prophylactic regimens against P. falciparum malaria: An update with pointers for future research. Schnyder JL; de Jong HK; Schlagenhauf P; Borrmann S; Hanscheid T; Grobusch MP Travel Med Infect Dis; 2022; 49():102365. PubMed ID: 35661741 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-saharan Africa. Leshem E; Meltzer E; Stienlauf S; Kopel E; Schwartz E J Travel Med; 2014; 21(2):82-5. PubMed ID: 24298915 [TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa. Lachish T; Bar-Meir M; Eisenberg N; Schwartz E J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401 [TBL] [Abstract][Full Text] [Related]
6. On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives. Schnyder JL; de Jong HK; Bache EB; van Hest RM; Schlagenhauf P; Borrmann S; Hanscheid T; Grobusch MP Travel Med Infect Dis; 2023; 52():102520. PubMed ID: 36526126 [TBL] [Abstract][Full Text] [Related]
7. Drug-free Holidays: Compliance, Tolerability, and Acceptability of a 3-Day Atovaquone/Proguanil Schedule for Pretravel Malaria Chemoprophylaxis in Australian Travelers. Lau CL; Ramsey L; Mills LC; Furuya-Kanamori L; Mills DJ Clin Infect Dis; 2019 Jun; 69(1):137-143. PubMed ID: 30281083 [TBL] [Abstract][Full Text] [Related]
8. Assessment of adherence to atovaquone-proguanil prophylaxis in travelers. DePetrillo JC; Singer C; Bergagnini IA; Kolakowski P; Edwards B; Smith MA J Travel Med; 2010; 17(4):217-20. PubMed ID: 20636593 [TBL] [Abstract][Full Text] [Related]
9. Vivax Malaria Chemoprophylaxis: The Role of Atovaquone-Proguanil Compared to Other Options. Meltzer E; Rahav G; Schwartz E Clin Infect Dis; 2018 May; 66(11):1751-1755. PubMed ID: 29228132 [TBL] [Abstract][Full Text] [Related]
10. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model. Deye GA; Miller RS; Miller L; Salas CJ; Tosh D; Macareo L; Smith BL; Fracisco S; Clemens EG; Murphy J; Sousa JC; Dumler JS; Magill AJ Clin Infect Dis; 2012 Jan; 54(2):232-9. PubMed ID: 22052893 [TBL] [Abstract][Full Text] [Related]
11. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil. Sutherland CJ; Laundy M; Price N; Burke M; Fivelman QL; Pasvol G; Klein JL; Chiodini PL Malar J; 2008 Nov; 7():240. PubMed ID: 19021900 [TBL] [Abstract][Full Text] [Related]
12. The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: A systematic review. Andrejko KL; Mayer RC; Kovacs S; Slutsker E; Bartlett E; Tan KR; Gutman JR Travel Med Infect Dis; 2019; 27():20-26. PubMed ID: 30654041 [TBL] [Abstract][Full Text] [Related]
13. Atovaquone and proguanil hydrochloride: a review of nonclinical studies. Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546 [TBL] [Abstract][Full Text] [Related]
14. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers. Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997 [TBL] [Abstract][Full Text] [Related]
15. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria. McKeage K; Scott L Drugs; 2003; 63(6):597-623. PubMed ID: 12656656 [TBL] [Abstract][Full Text] [Related]
16. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team. Høgh B; Clarke PD; Camus D; Nothdurft HD; Overbosch D; Günther M; Joubert I; Kain KC; Shaw D; Roskell NS; Chulay JD; Lancet; 2000 Dec; 356(9245):1888-94. PubMed ID: 11130385 [TBL] [Abstract][Full Text] [Related]
17. Malaria prophylaxis for aircrew: safety of atovaquone/proguanil in healthy volunteers under aircraft cabin pressure conditions. Simons R; Valk PJ; Krul AJ J Travel Med; 2005; 12(4):210-6. PubMed ID: 16086896 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark. Kofoed K; Petersen E J Travel Med; 2003; 10(3):150-4. PubMed ID: 12757688 [TBL] [Abstract][Full Text] [Related]
19. Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases. Cordel H; Cailhol J; Matheron S; Bloch M; Godineau N; Consigny PH; Gros H; Campa P; Bourée P; Fain O; Ralaimazava P; Bouchaud O Malar J; 2013 Nov; 12():399. PubMed ID: 24200190 [TBL] [Abstract][Full Text] [Related]
20. Malaria chemoprophylaxis with atovaquone-proguanil: is a shorter regimen fully protective? Grobusch MP J Travel Med; 2014; 21(2):79-81. PubMed ID: 24593022 [No Abstract] [Full Text] [Related] [Next] [New Search]